ArticleJournal of ophthalmic inflammation and infection2026
Outcomes of Patients with Acute Retinal Necrosis (ARN) presenting to a Canadian tertiary care centre: a 5-year retrospective cohort study.
Article in Journal of ophthalmic inflammation and infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo describe the contemporary management and outcomes of patients with acute retinal necrosis (ARN) at a tertiary Canadian hospital over a 5-year period.
methodsThis was a retrospective cohort study of patients who presented to The Ottawa Hospital (Ottawa, Canada) and were newly diagnosed with ARN between January 2019 and July 2024. Data regarding demographics, clinical presentation, investigations, treatment, and outcomes were collected. The primary outcome was retinal detachment. Secondary outcomes were severe vision loss and other complications associated with ARN. Statistical analyses were performed to identify factors associated with develop of the primary and secondary outcomes.
resultsA total of 16 eyes amongst 14 patients met inclusion criteria. The mean age at presentation was 56 years old, with 57% male. 5 patients (36%) had a known history of previous systemic herpetic infection. The most common exam findings on presentation were anterior chamber cell (94%), keratitic precipitates (88%), vitritis (94%), and arteritis (75%). Aqueous humor serology was positive for 96% of eyes (56% for VZV and 40% for HSV). Eyes received an average of 5.8 injections (range 1 to 17) of intravitreal antiviral therapy. Corticosteroids were administered in 13 patients (81%). Prophylactic laser retinopexy was used in 1 eye (6%) and pars plana vitrectomy was done for vitreous opacities in 1 eye (6%). During a mean follow-up of 424 days, 44% of eyes developed retinal detachment. The average time from symptom onset to diagnosis of retinal detachment was 105 days (range 14 to 180). Half of eyes had a final visual acuity worse than 20/200. The most common complications were cataract (38%) and recurrent anterior uveitis (31%). Initial BCVA of worse than 20/400 was significantly associated with an outcome of severe vision loss. No associations were found for development of retinal detachment.
conclusionOur cohort demonstrates the range of presentations and outcomes in the management of ARN. While early recognition and systemic antivirals remain essential, our centre uses a larger number of intravitreal antiviral injections with less prophylactic laser or vitrectomy to achieve similar outcomes as other cohorts. This study highlights the value of standardized protocols for recognition and treatment of ARN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.